Atrius Health Central OB/GYN CME Presents: OB/GYN October 2024 CME/CNE, 10/16/2024
Claiming Credit for Session
Thank you for attending Atrius Health's OB/GYN meeting on October 16, 2024. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to take an evaluation to claim your credit on the following page.
Educational Needs Addressed
In this meeting, Atrius Health discussed the current challenges, guideline advancements and treatment in OB/GYN practice as identified by their internal specialists and CME planning committee. The latest practice data and findings were discussed with the goal of further improving internal practice and treatments.
Target Audience
Atrius Health OB/GYN Clinicians
Learning Objectives
At the completion of this activity, participants will be better able to:
- Weight Loss Meds: Understand current evidence-based approach to GLP-1 receptor agonist therapy, including perioperative management and preconception/postpartum considerations.
- Provide update on most recent ACOG evidence-based guidelines and recommendations regarding clinical care
- Improve encounters and patient outcomes by applying principles of Trauma Informed Care
- Align personal practice with departmental and organizational goals
- Provide optimal cervical cancer screening and treatment in accordance with current guidelines
- Offer standard, evidence-based options and counseling for pain control during office procedures
- Provide optimal diagnostic care for routine vulvo/vaginal complaints
- Quality: provide update on Atrius Quality Management program/team and review trends in adverse events/outcomes
- Understand risks/benefits of new drug for hot flashes and prescribe accordingly
TIME | Min | OBGYN CME - OCTOBER 16, 2024 | WHO |
7:45–8:00 |
| Log on and say hello to your colleagues | Company |
8:00–8:05 | 5 | Introduction | Education Committee |
8:05-8:30 | 25 | Weight Loss Meds | Pascale Carbonara MD |
8:30-8:35 | 5 | ACOG Updates | Christopher Morrison, MD |
8:35-9:20 | 45 | Trauma Informed Pelvic Care | Kathryn Kieran, PMHNP-BC |
9:20-9:40 | 20 | OB/GYN Specialty Update | Tim Hale, MD, Michael Flynn |
9:40-9:50 | 10 | Break |
|
9:50-10:00 | 10 | Announcements & EPIC Updates | Christopher Morrison, MD |
10:00-10:25 | 25 | ASCCP Update | Liz Buechler MD |
10:25-10:45 | 20 | Pain Control Office Procedures | Emily Staudenmaier, DO |
10:45-10:55 | 10 | Vulvar Care Reminders | Meghan Bride, NP |
10:55-11:20 | 25 | Quality Updates | Cris Diaz, MD |
11:20-11:30 | 10 | Fezolinetant (Veozah) | Marcie Richardson MD |
Faculty Presenters and Disclosures
Christopher Morrison, MD
Course Director
Obstetrics and Gynecology
Atrius Health
Drs. Buechler, Dias, Flynn, Hale, Kiernan, Morrison, Richardson and Staudenmaier have no relevant financial relationships to disclose. Ms. Bride is a trainor for Organon/Merck. Dr. Carbonara is a consultant for Eli Lilly.
Planning Committee
Drs. Li, Mayhew, Morrison, Platek and Richardson have no relevant financial relationships to disclose. Meaghan Bride, NP is a trainer for Organon/Merck & Co.
Accreditor Disclosures
The following planning committee members from Boston University Chobanian & Avedisian School of Medicine’s Office of Continuing Medical Education have no relevant financial relationships:Michael Burk, BS, Operations Manager; Daniel Alford, MD, Assistant Dean.
Accreditor Disclosure Policy
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.
Off-Label Discussion
The faculty members do not plan on discussing the unlabeled/investigational use of any commercial products.
Disclaimer
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and Atrius Health. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Risk Management
This program includes 3.5 hours which meet the criteria of the Massachusetts Board of Registration in Medicine for risk management study.
Nursing Accreditation
Contact Hours: 3.5, of which 1.0 are eligible for pharmacology credit.
Interprofessional Continuing Education Credit
This activity was planned by and for the healthcare team, and learners will receive 3.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
Available Credit
- 3.50 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 3.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 3.50 MA Risk Management
- 3.50 ANCC
- 1.00 ANCC Pharmacology
- 3.50 Participation